logo
Visitors to Chitradurga fort find digital hurdle difficult to breach

Visitors to Chitradurga fort find digital hurdle difficult to breach

Deccan Herald9 hours ago
Hubballi: A section of visitors to the historical Chitradurga fort either return without seeing the legendary 'Obavvana kindi' or argue with guards at the gate to gain free entry as self-ticketing (by scanning QR code) fails to issue tickets due to poor internet connectivity and lengthy process of uploading details on the ASI-pay app..The ministry of culture, under which the Archaeological Survey of India (ASI) protected monument comes, has launched self-ticketing only system across India to minimise deployment of human resources at ticket counters, reduce operation cost (purchase of ticket rolls and vending machines) and reduce queue time..Chitradurga fort is one of the 25 monuments across India to pilot this initiative. However, forget the benefits, visitors to the fort are facing hardships..A security guard at Chitradurga fort said seven out of 10 attempts fail due to poor network..It takes at least 8-10 minutes for each transaction to complete as visitors have to fill in their details along with uploading identity proof and mobile numbers on the ASI-pay app..'Many visitors don't carry smart-phones or do not have phone-pay/G-pay. The network coverage at the fort is poor. So, it becomes very difficult to manage the crowd,' said another guard..As many as 16 centrally protected monuments in Karnataka have entry tickets..Among them, two monuments — Chitradurga fort and Tipu Sultan palace in Bengaluru — allow visitors only under self-ticketing system..Visitors have to scan a QR code placed at the entry gate via digital payment apps and buy tickets..Of the 25 monuments selected by ASI across India for this pilot project, two are in Karnataka..The ASI intends to implement self-ticketing system across all 250 centrally protected ticketed monuments in the country..A senior ASI official said the key main intention of the Ministry of Culture to implement ASI-pay app is to give Indian visitors Rs 5 discount and foreign visitors Rs 50 discount..However, multiple ASI officials and guides at Hampi and Vijayapura informed DH that the app, instead of helping visitors, was resulting in hardships..'Earlier, we used to deploy two staff to issue tickets at Vijayapura monuments. Now, with the government insisting on self-ticketing, we are deploying five staff on weekends to help tourists,' said a Dharwad circle officer of ASI..The app has also reduced mass booking of tickets. Only five persons can book a ticket per number..Basavaraj, a guide at Hampi, says visitors are facing problems while booking tickets at Lotus Mahal and Vittala temple complex due to poor network coverage..'A majority of visitors buy tickets at the counter though they are a bit costlier than booking through QR scanning method,' he says and adds the process should have been as simple as making a digital payment..An ASI officer at Hampi circle said the complaint had been brought to the notice of higher-ups..'The network issue wasn't brought to our notice, we will look into it,' he says..A senior officer in Bengaluru circle, under which Chitradurga fort and Tipu Sultan palace come, says they are just following orders from the ministry of culture..'We have been asked to issue tickets at these monuments only via QR code scanning. Officials in Delhi or regional directors can take a call on reactivating booking counters,' he says.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Railway Minister: 'Make in India' boosting rail exports, coaches sent to Australia, bogies to UK
Railway Minister: 'Make in India' boosting rail exports, coaches sent to Australia, bogies to UK

Time of India

time5 minutes ago

  • Time of India

Railway Minister: 'Make in India' boosting rail exports, coaches sent to Australia, bogies to UK

Railway Minister Ashwini Vaishnaw visited Alstom's coach manufacturing unit in Vadodara, where metro and intercity train coaches are being built for Indian and international routes. He highlighted India's growing rail exports under the 'Make in India, Make for the World' vision, with coaches and components being shipped to countries including Australia, Canada, UK, Saudi Arabia, and France. Show more Show less

IT sector not broken, but evolving, says TRUST MF's CIO Mihir Vohra; shares top sectoral bets
IT sector not broken, but evolving, says TRUST MF's CIO Mihir Vohra; shares top sectoral bets

Mint

time5 minutes ago

  • Mint

IT sector not broken, but evolving, says TRUST MF's CIO Mihir Vohra; shares top sectoral bets

Mihir Vora, CIO, TRUST Mutual Fund, believes that the Indian stock market could step out of its consolidation zone once global volatility subsides and investor focus returns to earnings. Meanwhile, Vohra remains unperturbed by the ongoing FII selloff, as DII support and SIP inflows bolster confidence in equity demand. He is bullish on select sectors like infrastructure, logistics, and defence suppliers, NBFCs, among others. Edited excerpts: The Nifty has been churning in a tight band for several weeks. The domestic and global macroeconomic and geopolitical setup has many moving parts, and markets are probably waiting for a reduction in uncertainty. Globally, US trade negotiations are still on, and the US Dollar continues to be weak in spite of high bond yields. Domestically, the long-term macro parameters are healthy – low inflation, improving current account deficit and fiscal deficit. Consumption indicators are a mixed bag, and credit growth has not yet picked up in spite of ample liquidity and rate cuts. In the short term, the earnings season has seen a mix of negative and positive surprises. Sustained earnings growth remains key for the market. If global volatility subsides and investor focus returns to domestic earnings, that could be enough to lift sentiment. Clarity on a U.S.–India trade agreement by the August 1 deadline can also be a catalyst. Foreign portfolio investors have turned cautious again — derivative positioning suggests the most bearish sentiment in months. That may continue until we get clear signals on U.S. Fed policy or trade developments. In the medium to long-term, if the US Dollar continues to remain relatively weak, we should see sustained flows to countries like India. We see FPI selling as cyclical rather than structural. In time, India's superior long-term macro, demographics and higher growth should bring global interest back. India also has a strong internal support system: domestic institutions remain net buyers, and record retail SIP flows continue to underpin demand. Overall, we have an underweight stance in the IT sector. We are tackling the sector exposure selectively, preferring midcap IT names and digital infra providers with stronger growth visibility, rather than overcrowded large caps. Even within the blue-chips, firms executing well on AI/automation and client-based cost takeout remain interesting. The sector isn't broken — it's just evolving. While the leading IT giants delivered subdued numbers — flat revenues, soft global deal wins — valuations are now trading closer to historical norms than early 2024 extremes. Our growth conviction remains highest in capex, power transmission, infrastructure logistics, and defence suppliers—segments with visible order books, operating leverage, and a longer runway of growth. However, we are selective as these segments have become quite popular and valuations are not uniformly attractive. Financials offer opportunities in NBFCs and banks, with expectations of improving credit growth and asset quality. Auto ancillaries and engineering services/export plays are also showing promise as the global capex cycle recovers. In healthcare, the stories are more stock-specific, and we like the CDMO space and hospitals. After sharp rallies in many names, investors have started booking profits. The pullback is a natural consolidation, not a capitulation. The long-term fundamentals — rising defence budgets, dual-use platform opportunities, and improving export arcs — remain intact. Stock selection is critical now. We favour robust balance sheets, clear execution histories, and firms with pipeline visibility. Yes, we launched our third equity fund, the Multicap Fund. This continues our efforts to offer funds in all the core categories to our investors and distributors, the first two being the Flexi Cap and Small Cap funds. The Multicap category is a core category and is suitable for most investors who want a diversified exposure to the stock market. Disclaimer: This story is for educational purposes only. The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.

Nifty Pharma Index rises 1% amid weak India Stock Markets: Cipla and Laurus Labs among key gainers
Nifty Pharma Index rises 1% amid weak India Stock Markets: Cipla and Laurus Labs among key gainers

Mint

time5 minutes ago

  • Mint

Nifty Pharma Index rises 1% amid weak India Stock Markets: Cipla and Laurus Labs among key gainers

Stock Market Today: The Nifty Pharma Index gained more than 1% amid a weak Indian stock market on a day when the benchmark Nifty 50 Index dipped 0.3-0.4% during the intraday trades. Cipla and Laurus Labs stood among the key gainers The Nifty Pharma index, showing its resilience, gained more than 1% during the intraday trades. The Nifty Pharma Index, which opened at 22690.50 on Monday, went to scale highs of 22,908.40, marking gains of more than 1% over the previous day's close of 22662.70. Laurus Labs, with gains of more than 7%, followed by Cipla, with gains of close to 2%, stood among key gainers. Glenmark Pharmaceuticals and Gland Pharma also gained more than 1%, helping drive gains. Nifty Pharma and Healthcare index have been showing resilience amid volatile stock markets since last few weeks While Nifty Pharma & Healthcare are the lone warriors displaying outperformance amidst this downfall in the markets, we expect sectors such as IT, Defense, Oil & Gas, Realty & CPSE to appear bearish and may continue to underperform in the near term, given their weak price structures and lackluster momentum indicators., said Sudeep Shah, Vice President and Head of Technical and Derivative Research, SBI Securities Technically, Cipla, Apollo Hospital are likely to outperform in the short term, as per Shah. The Indian Pharma index performance is also being helped by strong Indian Pharma market growth. The IPM growth during the month of June 2025 stood at a strong 11.5%, as per reports. Glemmark Pharmaceuticals, JB Chemicals and Pharmaceuticals, Mankind Pharma FDC Ltd, Alkem, Zydus, and Torrent were among the key outperformers as per Nuvama. While the pharma market is growing, the challenge is provided by rising generic sales and Jan Aushadhi Kendras. However, amidst challenges, Within formulations, Sun, Cipla, Lupin and Emcure are the top picks. of Kotak Institutional Equities Disclaimer: The views and recommendations above are those of individual analysts or brokerage companies, not Mint. We advise investors to check with certified experts before making any investment decisions.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store